YWHAZ and cancer: Most of the evidence supporting a role for 14-3-3s in promoting chemoresistance and poor patient outcomes focuses on the 14-3-3ζ gene (YWHAZ), which resides within the 8q22.3 chromosomal region which is frequently duplicated in cancer [11, 12].